Serono in talks with top pharma companies about potential takeover

Share this article:
Serono has held talks with Novartis, GlaxoSmithKline, Sanofi-Aventis and Pfizer in recent weeks about a potential $15 billion takeover of the company, The Wall Street Journal reported today.
Serono, based in Geneva, Switzerland, is the world's third largest biotech company by sales.
In a statement, the company said that it has hired investment bank Goldman Sachs Group "to explore various strategic alternatives for the company," adding that "there can be no assurances that any transaction will be consummated."
Any buyer would most likely be interested in Serono's multiple sclerosis drug Rebif, which had sales of $1 billion in 2004. The company also sells drugs to treat infertility and is attempting to develop 30 new medicines for cancer, inflammatory diseases and other therapeutic areas.
Share this article:
close

Next Article in News

Email Newsletters

More in News

Meaningful use not linked to quality: study

Meaningful use not linked to quality: study

A recent study of physicians found no correlation between following EHR meaningful use requirements and providing consistently higher quality of care.

Lilly Q1 sales dip

Lilly Q1 sales dip

US sales fell 34% during the quarter, largely due to lower demand and lower prices for off-patent Cymbalta and Evista.

Gilead reaps huge HCV sales, payer fury

Gilead reaps huge HCV sales, payer fury

Sovaldi's debut has been marked by plenty of criticism from payers and lawmakers, but the hep. C drug's launch, now confirmed to be the fastest of all time, has also ...